{"id":"https://openalex.org/W4362525108","doi":"https://doi.org/10.1158/2326-6066.c.6549919","title":"Data from ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome","display_name":"Data from ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362525108","doi":"https://doi.org/10.1158/2326-6066.c.6549919"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.c.6549919","doi":"https://doi.org/10.1158/2326-6066.c.6549919","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6549919","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.c.6549919","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072042134","display_name":"Claire Y. Oh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claire Y. Oh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061721767","display_name":"Martin G. Klatt","orcid":"https://orcid.org/0000-0001-8703-7305","observed_orcids":["https://orcid.org/0000-0001-8703-7305"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin G. Klatt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8703-7305","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Christopher Bourne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Bourne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062508226","display_name":"Tao Dao","orcid":"https://orcid.org/0000-0001-9937-6283","observed_orcids":["https://orcid.org/0000-0001-9937-6283"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tao Dao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006955363","display_name":"Megan M. Dacek","orcid":"https://orcid.org/0000-0003-1731-1502","observed_orcids":["https://orcid.org/0000-0003-1731-1502"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Megan M. Dacek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035010583","display_name":"Elliott Joseph Brea","orcid":"https://orcid.org/0000-0002-6283-0267","observed_orcids":["https://orcid.org/0000-0002-6283-0267"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elliott J. Brea","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6283-0267","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063386932","display_name":"Sung Soo Mun","orcid":"https://orcid.org/0000-0002-3735-6057","observed_orcids":["https://orcid.org/0000-0002-3735-6057"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sung Soo Mun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073815714","display_name":"Aaron Y. Chang","orcid":"https://orcid.org/0000-0002-7770-7405","observed_orcids":["https://orcid.org/0000-0002-7770-7405"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aaron Y. Chang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7770-7405","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036716982","display_name":"Tatyana Korontsvit","orcid":"https://orcid.org/0000-0001-6319-1797","observed_orcids":["https://orcid.org/0000-0001-6319-1797"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tatyana Korontsvit","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6319-1797","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006680533","display_name":"David A. Scheinberg","orcid":"https://orcid.org/0000-0002-4160-923X","observed_orcids":["https://orcid.org/0000-0002-4160-923X","https://orcid.org/0009-0009-0651-7389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Scheinberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.725600004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.725600004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.2612000107765198,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.008899999782443047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/ret-inhibitors","display_name":"RET inhibitors","score":1.0},{"id":"https://openalex.org/keywords/hla-class-i-antigen-presentation","display_name":"HLA class I antigen presentation","score":0.9279999732971191},{"id":"https://openalex.org/keywords/tumor-immunopeptidome","display_name":"tumor immunopeptidome","score":0.9589999914169312},{"id":"https://openalex.org/keywords/t-cell-epitopes","display_name":"T cell epitopes","score":0.6909999847412109},{"id":"https://openalex.org/keywords/antigen-processing-machinery","display_name":"antigen processing machinery","score":0.6380000114440918},{"id":"https://openalex.org/keywords/pd-l1-downregulation","display_name":"PD-L1 downregulation","score":0.875},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.703000009059906},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7580000162124634},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.578000009059906},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6945428848266602},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.6485909223556519},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6137768030166626},{"id":"https://openalex.org/C83464605","wikidata":"https://www.wikidata.org/wiki/Q575296","display_name":"Antigen presentation","level":4,"score":0.5746071338653564},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.4957031011581421},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.48460137844085693},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4821338355541229},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.4797871708869934},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4467217028141022},{"id":"https://openalex.org/C108249834","wikidata":"https://www.wikidata.org/wiki/Q3922363","display_name":"Antigen processing","level":5,"score":0.4444517493247986},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.40064537525177},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3970467448234558},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3899981677532196},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.37677001953125},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.363484263420105},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3389449715614319},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12749627232551575},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08848249912261963}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.c.6549919","doi":"https://doi.org/10.1158/2326-6066.c.6549919","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6549919","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.c.6549919","doi":"https://doi.org/10.1158/2326-6066.c.6549919","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6549919","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2973356852","https://openalex.org/W2795499450","https://openalex.org/W2750228412","https://openalex.org/W2084714208","https://openalex.org/W2086525270","https://openalex.org/W3036523796","https://openalex.org/W2078176534","https://openalex.org/W4411494869","https://openalex.org/W1984550821","https://openalex.org/W2948878593"],"abstract_inverted_index":{"Abstract":[0],"T-cell":[1,88],"immunotherapies":[2,132],"are":[3],"often":[4],"thwarted":[5],"by":[6,14,103,112,120,133],"the":[7,15,77,80,117],"limited":[8],"presentation":[9],"of":[10,17,56,64,82,84],"tumor-specific":[11],"antigens":[12],"abetted":[13],"downregulation":[16],"human":[18],"leukocyte":[19],"antigen":[20],"(HLA).":[21],"We":[22],"showed":[23],"that":[24],"drugs":[25],"inhibiting":[26],"ALK":[27,68,97,127],"and":[28,45,53,58,69,126,140],"RET":[29,70,125],"produced":[30],"dose-related":[31],"increases":[32],"in":[33,36,43,46,76],"cell-surface":[34],"HLA":[35,57,122],"tumor":[37],"cells":[38],"bearing":[39],"these":[40,106],"mutated":[41],"kinases":[42],"vitro":[44],"vivo,":[47],"as":[48,50],"well":[49],"elevated":[51],"transcript":[52],"protein":[54],"expression":[55],"other":[59],"antigen-processing":[60],"machinery.":[61],"Subsequent":[62],"analysis":[63],"HLA-presented":[65],"peptides":[66],"after":[67],"inhibitor":[71],"treatment":[72],"identified":[73],"large":[74],"changes":[75],"immunopeptidome":[78],"with":[79,91],"appearance":[81],"hundreds":[83],"new":[85],"antigens,":[86],"including":[87],"epitopes":[89],"associated":[90],"impaired":[92],"peptide":[93],"processing":[94],"(TEIPP)":[95],"peptides.":[96],"inhibition":[98],"additionally":[99],"decreased":[100],"PD-L1":[101],"levels":[102],"75%.":[104],"Therefore,":[105],"oncogenes":[107],"may":[108],"enhance":[109,130],"cancer":[110],"formation":[111],"allowing":[113],"tumors":[114],"to":[115],"evade":[116],"immune":[118],"system":[119],"downregulating":[121],"expression.":[123],"Altogether,":[124],"inhibitors":[128],"could":[129],"T-cell\u2013based":[131],"upregulating":[134],"HLA,":[135],"decreasing":[136],"checkpoint":[137],"blockade":[138],"ligands,":[139],"revealing":[141],"new,":[142],"immunogenic,":[143],"cancer-associated":[144],"antigens.":[145]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-04-06T00:00:00"}